Lahore High Court accepts Musharraf's petition seeking to stop verdict in high treason case

Image
Press Trust of India Lahore
Last Updated : Nov 26 2019 | 2:15 PM IST

The Lahore High Court on Tuesday accepted a petition to hear the plea from the ailing former military ruler Pervez Musharraf seeking to stop the special court from announcing its reserved verdict in the high treason case against him on Thursday, according to media reports.

Justice Syed Mazhar Ali Akbar Naqvi of the Lahore High Court (LHC) removed its objections and admitted Dubai-based Musharraf's petition for hearing, the Dawn News reported.

The LHC also sought replies from the federal government and the Ministry of Interior by November 28.

A separate petition was also filed by the interior ministry in the Islamabad High Court to stop the special tribunal from issuing its verdict in the treason case against Musharraf.

On Monday Justice Naqvi had directed Musharraf's lawyer Khwaja Ahmed to give arguments regarding the maintainability of the petition.

The LHC had questioned whether the plea falls under its jurisdiction as the 76-year-old former president is a resident of Islamabad, the Geo News reported.

The court had also said that the case is with the Supreme Court and under the circumstances the petitioner should reach out to the apex court.

The special court had on November 19 concluded the trial proceedings in the high treason case against Musharraf for declaring a state of emergency in 2007 and had ruled that a verdict would be announced on November 28.

Musharraf, who is living in Dubai in self-exile, challenged the special court verdict in the LHC on Saturday and sought suspension of his trial in absentia.

If found guilty, Musharraf could be sentenced to death.

The petitioner said that since Musharraf was not present in the country, the tribunal should be asked to wait until he got well and came back to face the trial.

According to Pakistani media reports, Musharraf suffers from amyloidosis, a rare disease caused by the build-up of an abnormal protein called amyloid in organs and tissues in the body, and is under medication

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Nov 26 2019 | 2:15 PM IST

Next Story